A novel lipopolysaccharide-antagonizing aptamer protects mice against endotoxemia

Biochemical and Biophysical Research Communications

Volumn 382, Issue 1, 2009, Pages 140-144

  Wen, Ai qing ^a   Yang, Qing wu ^a   Li, Jing cheng ^a   Lv, Feng ling ^b   Zhong, Qi ^a   Chen, Cai yu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING UNIVERSITY   (China)

Author keywords

Aptamers; Lipopolysaccharide; Proinflammatory; SELEX; Septic shock

Indexed keywords

APTAMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; SINGLE STRANDED DNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; GENE SEQUENCE; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEQUENCE ANALYSIS; SURVIVAL RATE;

ANIMALS; APTAMERS, NUCLEOTIDE; DNA, SINGLE-STRANDED; DRUG EVALUATION, PRECLINICAL; ENDOTOXEMIA; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MONOCYTES; NF-KAPPA B; NUCLEIC ACID CONFORMATION; SELEX APTAMER TECHNIQUE;

MUS;

EID: 63149095246     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.152     Document Type: Article

References (27)

1. Downey J.S., and Han J. Cellular activation mechanism in septic shock. Front. Biosci. 3 (1998) d468-d476
2. Tall A. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64 (1995) 235-257
3. Jean-Baptiste E. Cellular mechanisms in sepsis. J. Intensive Care Med. 22 (2007) 63-72
4. Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 26 (2000) s64
5. Brun-Buisson C., Doyon F., Carlet J., Della-monica P., Gouin F., Lepoutre A., Mericer J.C., Offenstadt G., and Regnier B. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units, French ICU Group for severe sepsis. JMMA 274 (1995) 968-974
6. Johnson G.B., Brunn G.J., Samstein B., and Platt J.L. New insight into the pathogenesis of sepsis and the sepsis syndrome. Surgery 137 (2005) 393-395
7. Munford R.S. Severe sepsis and septic shock: the role of Gram-negative bacteremia. Annu. Rev. Pathol. 1 (2006) 467-496
8. Li Y., Shi F., Li Y., and Wang X. Structure and function of lipopolysaccharide lipid A in bacteria-a review. Wei Sheng Wu Xue Bao 48 (2008) 844-849
9. Jin M.S., and Lee J.O. Structures of the toll-like receptor family and its ligand complexes. Immunity 29 (2008) 182-191
10. Right S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
11. Youn J.H., Oh Y.J., Kim E.S., Choi J.E., and Shin J.S. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J. Immunol. 180 (2008) 5067-5074
12. Opal S.M., and Yu Jr. R.L. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions. Drugs 55 (1998) 497-508
13. Bone R.C., Balk R.A., Fein A.M., Perl T.M., Wenzel R.P., Reines H.D., Quenzer R.W., Iberti T.J., Macintyre N., and Schein R.M. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit. Care Med. 23 (1995) 994-1006
14. Christ W.J., Asano O., Robidoux A.L., Perez M., Wang Y., Dubuc G.R., Gavin W.E., Hawkins L.D., McGuinness P.D., and Mullarkey M.A. E5531, a pure endotoxin antagonist of high potency. Science 268 (1995) 80-83
15. Bunnell E., Lynn M., Habet K., Neumann A., Perdomo C.A., Friedhoff L.T., Rogers S.L., and Parrillo J.E. A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia. Crit. Care Med. 28 (2000) 2713-2720
16. Wang D.N., Zhang W.J., and Wu X.F. The new antiendotoxin strategies. Chin. J. Biotechnol. 17 (2001) 242-245
17. Hermann T., and Patel D.J. Adaptive recognition by nucleic acid aptamers. Science 287 (2000) 820-825
18. Rusconi C.P., Scardino E., Layzer J., Pitoc G.A., Ortel T.L., and Monroe D.B.A. RNA aptamers as reversible antagonists of coagulation factor XIa. Nature 419 (2002) 90-94
19. Darfeuille F., Arzumanov A., Gait M.J., Di Primo C., and Toulmé J.J. 2′-O-Methyl-RNA hairpins generate loop-loop complexes and selectively inhibit HIV-1 Tat-mediated transcription. Biochemistry 41 (2002) 12186-12192
20. Faria M., and Ulrich H. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Curr. Cancer Drug Targets 2 (2002) 355-368
21. Drolet D.W., Nelson J., Tucker C.E., Zack P.M., Nixon K., Bolin R., Judkins M.B., Farmer J.A., Wolf J.L., Gill S.C., and Bendele R.A. Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm. Res. 17 (2000) 1503-1510
22. Yang Q.W., Wen A.Q., Lv F.L., and Chen C.Y. A procedure for SELEX screening aptamers of LPS from ssDNA random library. Chong Qing Yi Xue 37 (2008) 1773-1775
23. Cheng C., Dong J., Yao L., Chen A., Jia R., Huan L., Guo J., Shu Y., and Zhang Z. Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX. Biochem. Biophys. Res. Commun. 366 (2008) 670-674
24. Yang Q.W., Mou L., Lv F.L., Zhu P.F., Wang Z.G., Jiang J.X., and Wang J.Z. Novel TLR4-antagonizing peptides inhibit LPS-induced release of inflammatory mediators by monocytes. Biochem. Biophys. Res. Commun. 329 (2005) 846-854
25. Macagno A., Molteni M., Rinaldi A., Bertoni F., Lanzavecchia A., Rossetti C., and Sallusto F. A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J. Exp. Med. 203 (2006) 1481-1492
26. Drolet D.W., Jenison R.D., Smith D.E., Pratt D., and Hicke B.J. A high throughput platform for systematic evolution of ligands by exponential enrichment. Comb. Chem. High Throughput Screen. 5 (1999) 271-278
27. Kimoto M., Shirouzu M., Mizutani S., Koide H., Kaziro Y., Hirao I., and Yokoyama S. Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation. Eur. J. Biochem. 269 (2002) 697-704